Use of proteomic patterns in serum to identify ovarian cancer Academic Article Article uri icon

Overview

MeSH Major

  • Antineoplastic Agents
  • Antineoplastic Combined Chemotherapy Protocols
  • Genital Neoplasms, Female

abstract

  • These findings justify a prospective population-based assessment of proteomic pattern technology as a screening tool for all stages of ovarian cancer in high-risk and general populations.

publication date

  • February 16, 2002

Research

keywords

  • Academic Article

Identity

Digital Object Identifier (DOI)

  • 10.1016/S0140-6736(02)07746-2

PubMed ID

  • 11867112

Additional Document Info

start page

  • 572

end page

  • 7

volume

  • 359

number

  • 9306